FDA Logo links to FDA home page
Center for Biologics Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Biologics Evaluation and Research
 HHS Logo links to Department of Health and Human Services website

FDA Home Page | CBER A-Z Index | CBER Search | Contact CBER | CBER Home Page

horizontal rule
CBER links to product areas
CBER links
horizontal rule

Product Approval Information - Licensing Action

horizontal rule

Proper name: Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed
Tradename: Acel-Imune
Manufacturer: Lederle Laboratories Division American Cyanamid Co, Pearl River, New York, License #0017
Indication for Use: New indication for use as a three dose primary series in children at least six weeks of age and for the fourth and fifth dose in children who have received three doses of DTaP or Diphtheria and Tetanus Toxoids and Pertussis Vaccine Adsorbed
Approval Date: 12/30/96
Type of submission: Product license supplement

horizontal rule

Approval Letter - (PDF), (Text)

Label - (PDF)

 

 
horizontal rule